Chapter/Section Purchase

1 Parkinsons Disease Drug Market Overview
1.1 Product Overview and Scope of Parkinsons Disease Drug
1.2 Parkinsons Disease Drug Segment by Type
1.2.1 Global Parkinsons Disease Drug Sales Growth Rate Comparison by Type (2023-2029)
1.2.2 Carbidopa/Levodopa
1.2.3 Dopamine Receptor Agonists
1.2.4 MAO-Inhibitors
1.3 Parkinsons Disease Drug Segment by Application
1.3.1 Global Parkinsons Disease Drug Sales Comparison by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Global Parkinsons Disease Drug Market Size Estimates and Forecasts
1.4.1 Global Parkinsons Disease Drug Revenue 2018-2029
1.4.2 Global Parkinsons Disease Drug Sales 2018-2029
1.4.3 Parkinsons Disease Drug Market Size by Region: 2018 Versus 2022 Versus 2029
2 Parkinsons Disease Drug Market Competition by Manufacturers
2.1 Global Parkinsons Disease Drug Sales Market Share by Manufacturers (2018-2023)
2.2 Global Parkinsons Disease Drug Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Parkinsons Disease Drug Average Price by Manufacturers (2018-2023)
2.4 Manufacturers Parkinsons Disease Drug Manufacturing Sites, Area Served, Product Type
2.5 Parkinsons Disease Drug Market Competitive Situation and Trends
2.5.1 Parkinsons Disease Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Parkinsons Disease Drug Players Market Share by Revenue
2.5.3 Global Parkinsons Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Parkinsons Disease Drug Retrospective Market Scenario by Region
3.1 Global Parkinsons Disease Drug Retrospective Market Scenario in Sales by Region: 2018-2023
3.2 Global Parkinsons Disease Drug Retrospective Market Scenario in Revenue by Region: 2018-2023
3.3 North America Parkinsons Disease Drug Market Facts & Figures by Country
3.3.1 North America Parkinsons Disease Drug Sales by Country
3.3.2 North America Parkinsons Disease Drug Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Parkinsons Disease Drug Market Facts & Figures by Country
3.4.1 Europe Parkinsons Disease Drug Sales by Country
3.4.2 Europe Parkinsons Disease Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Parkinsons Disease Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Parkinsons Disease Drug Sales by Region
3.5.2 Asia Pacific Parkinsons Disease Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Parkinsons Disease Drug Market Facts & Figures by Country
3.6.1 Latin America Parkinsons Disease Drug Sales by Country
3.6.2 Latin America Parkinsons Disease Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Parkinsons Disease Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Parkinsons Disease Drug Sales by Country
3.7.2 Middle East and Africa Parkinsons Disease Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Parkinsons Disease Drug Historic Market Analysis by Type
4.1 Global Parkinsons Disease Drug Sales Market Share by Type (2018-2023)
4.2 Global Parkinsons Disease Drug Revenue Market Share by Type (2018-2023)
4.3 Global Parkinsons Disease Drug Price by Type (2018-2023)
5 Global Parkinsons Disease Drug Historic Market Analysis by Application
5.1 Global Parkinsons Disease Drug Sales Market Share by Application (2018-2023)
5.2 Global Parkinsons Disease Drug Revenue Market Share by Application (2018-2023)
5.3 Global Parkinsons Disease Drug Price by Application (2018-2023)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Parkinsons Disease Drug Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Teva Parkinsons Disease Drug Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Novartis AG
6.2.1 Novartis AG Corporation Information
6.2.2 Novartis AG Description and Business Overview
6.2.3 Novartis AG Parkinsons Disease Drug Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Novartis AG Parkinsons Disease Drug Product Portfolio
6.2.5 Novartis AG Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Parkinsons Disease Drug Sales, Revenue and Gross Margin (2018-2023)
6.3.4 GSK Parkinsons Disease Drug Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 AbbVie
6.4.1 AbbVie Corporation Information
6.4.2 AbbVie Description and Business Overview
6.4.3 AbbVie Parkinsons Disease Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 AbbVie Parkinsons Disease Drug Product Portfolio
6.4.5 AbbVie Recent Developments/Updates
6.5 Merck
6.5.1 Merck Corporation Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck Parkinsons Disease Drug Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Merck Parkinsons Disease Drug Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Corporation Information
6.6.2 Boehringer Ingelheim Description and Business Overview
6.6.3 Boehringer Ingelheim Parkinsons Disease Drug Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Boehringer Ingelheim Parkinsons Disease Drug Product Portfolio
6.6.5 Boehringer Ingelheim Recent Developments/Updates
6.7 Impax Laboratories
6.6.1 Impax Laboratories Corporation Information
6.6.2 Impax Laboratories Description and Business Overview
6.6.3 Impax Laboratories Parkinsons Disease Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Impax Laboratories Parkinsons Disease Drug Product Portfolio
6.7.5 Impax Laboratories Recent Developments/Updates
6.8 Lundbeck
6.8.1 Lundbeck Corporation Information
6.8.2 Lundbeck Description and Business Overview
6.8.3 Lundbeck Parkinsons Disease Drug Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Lundbeck Parkinsons Disease Drug Product Portfolio
6.8.5 Lundbeck Recent Developments/Updates
6.9 Sun Pharma
6.9.1 Sun Pharma Corporation Information
6.9.2 Sun Pharma Description and Business Overview
6.9.3 Sun Pharma Parkinsons Disease Drug Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Sun Pharma Parkinsons Disease Drug Product Portfolio
6.9.5 Sun Pharma Recent Developments/Updates
6.10 Wockhardt
6.10.1 Wockhardt Corporation Information
6.10.2 Wockhardt Description and Business Overview
6.10.3 Wockhardt Parkinsons Disease Drug Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Wockhardt Parkinsons Disease Drug Product Portfolio
6.10.5 Wockhardt Recent Developments/Updates
6.11 UCB
6.11.1 UCB Corporation Information
6.11.2 UCB Parkinsons Disease Drug Description and Business Overview
6.11.3 UCB Parkinsons Disease Drug Sales, Revenue and Gross Margin (2018-2023)
6.11.4 UCB Parkinsons Disease Drug Product Portfolio
6.11.5 UCB Recent Developments/Updates
6.12 Bausch Health
6.12.1 Bausch Health Corporation Information
6.12.2 Bausch Health Parkinsons Disease Drug Description and Business Overview
6.12.3 Bausch Health Parkinsons Disease Drug Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Bausch Health Parkinsons Disease Drug Product Portfolio
6.12.5 Bausch Health Recent Developments/Updates
6.13 Acadia
6.13.1 Acadia Corporation Information
6.13.2 Acadia Parkinsons Disease Drug Description and Business Overview
6.13.3 Acadia Parkinsons Disease Drug Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Acadia Parkinsons Disease Drug Product Portfolio
6.13.5 Acadia Recent Developments/Updates
7 Parkinsons Disease Drug Manufacturing Cost Analysis
7.1 Parkinsons Disease Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Parkinsons Disease Drug
7.4 Parkinsons Disease Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Parkinsons Disease Drug Distributors List
8.3 Parkinsons Disease Drug Customers
9 Parkinsons Disease Drug Market Dynamics
9.1 Parkinsons Disease Drug Industry Trends
9.2 Parkinsons Disease Drug Market Drivers
9.3 Parkinsons Disease Drug Market Challenges
9.4 Parkinsons Disease Drug Market Restraints
10 Global Market Forecast
10.1 Parkinsons Disease Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Parkinsons Disease Drug by Type (2023-2029)
10.1.2 Global Forecasted Revenue of Parkinsons Disease Drug by Type (2023-2029)
10.2 Parkinsons Disease Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Parkinsons Disease Drug by Application (2023-2029)
10.2.2 Global Forecasted Revenue of Parkinsons Disease Drug by Application (2023-2029)
10.3 Parkinsons Disease Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Parkinsons Disease Drug by Region (2023-2029)
10.3.2 Global Forecasted Revenue of Parkinsons Disease Drug by Region (2023-2029)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer